BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25029913)

  • 1. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.
    Wu SL; Bai JG; Xu J; Ma QY; Wu Z
    World J Surg Oncol; 2014 Jul; 12():220. PubMed ID: 25029913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome.
    Halvorson SA; Gilbert E; Hopkins RS; Liu H; Lopez C; Chu M; Martin M; Sheppard B
    J Gen Intern Med; 2013 Nov; 28(11):1525-9. PubMed ID: 23681843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagonoma syndrome with severe erythematous rash: A rare case report.
    Wang ZX; Wang F; Zhao JG
    Medicine (Baltimore); 2019 Sep; 98(37):e17158. PubMed ID: 31517863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagonoma Syndrome: A Rare Paraneoplastic Disorder due to Neuroendocrine Tumor of the Pancreas.
    Yusuf MA; Mehmood S; Iftikhar J; Saqib M; Siddique MZ; Imtiaz W
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):S147-S149. PubMed ID: 36210677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
    Saavedra C; Lamarca A; Hubner RA
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
    Tseng HC; Liu CT; Ho JC; Lin SH
    Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon cell adenomatosis: a new entity associated with necrolytic migratory erythema and glucagonoma syndrome.
    Otto AI; Marschalko M; Zalatnai A; Toth M; Kovacs J; Harsing J; Tulassay Z; Karpati S
    J Am Acad Dermatol; 2011 Aug; 65(2):458-459. PubMed ID: 21763589
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucagonoma syndrome with necrolytic migratory erythema as initial manifestation.
    Zhu WF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2021 Dec; 20(6):598-600. PubMed ID: 34544669
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.
    Perrier M; Brugel M; Gérard L; Goichot B; Lièvre A; Lepage C; Hautefeuille V; Do Cao C; Smith D; Thuillier P; Cros J; Cadiot G; Walter T; de Mestier L
    Eur J Endocrinol; 2023 Dec; 189(6):575-583. PubMed ID: 38039101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency pancreatic resection for glucagonoma associated with severe necrolytic migratory erythema.
    Daly DM; Thompson B; Low J; Slater J; Wood G; Kamath V; Haghighi KS
    ANZ J Surg; 2019 May; 89(5):599-602. PubMed ID: 28982222
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic glucagonoma with pancreatic calcification.
    Gupta RA; Udwadia FE; Agrawal P; Doctor N
    Pancreatology; 2013; 13(3):327-9. PubMed ID: 23719610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrolytic migratory erythema associated with a metastatic neuroendocrine tumor.
    Lolis MS; Krishtul A; Vidal C; Shim-Chang H; Phelps R; Lebwohl M
    Cutis; 2011 Feb; 87(2):78-80. PubMed ID: 21416773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
    Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].
    Siegel R; Linse R; Rau B
    Chirurg; 2006 Jun; 77(6):535-8. PubMed ID: 16362349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrolytic migratory erythema: an important sign of glucagonoma.
    Cui M; Wang R; Liao Q
    Postgrad Med J; 2021 Mar; 97(1145):199. PubMed ID: 32527759
    [No Abstract]   [Full Text] [Related]  

  • 17. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
    Tolliver S; Graham J; Kaffenberger BH
    Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Necrolytic migratory erythema in a patient with a glucagonoma].
    Demirbas M; Prens B
    Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma.
    Li W; Yang X; Deng Y; Jiang Y; Xu G; Li E; Wu Y; Ren J; Ma Z; Dong S; Han L; Ma Q; Wu Z; Wang Z
    Sci Rep; 2022 May; 12(1):9053. PubMed ID: 35641533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image Gallery: Necrolytic migratory erythema associated with glucagonoma.
    Aragón-Miguel R; Prieto-Barrios M; Calleja-Algarra A; Pinilla-Martin B; Rodriguez-Peralto J; Ortiz-Romero P; Rivera-Diaz R
    Br J Dermatol; 2019 Jan; 180(1):e1. PubMed ID: 30604550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.